HSBC Holdings
EVH icon

HSBC Holdings’s Evolent Health EVH Stock Holding History

HSBC Holdings’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Hold
161,125
– – ﹤0.01% 2370
2025
Q4 		$640K Sell
161,125
-49,868
-24% -$277K ﹤0.01% 2181
2025
Q3 		$1.8M Buy
210,993
+199,593
+1,751% +$1.94M ﹤0.01% 1545
2025
Q2 		$128K Sell
11,400
-99,996
-90% -$918K ﹤0.01% 2801
2025
Q1 		$1.05M Buy
111,396
+54,186
+95% +$547K ﹤0.01% 1734
2024
Q4 		$632K Buy
+57,210
New +$1.01M ﹤0.01% 2046
2024
Q3 		– Sell
-12,701
Closed -$248K – 3028
2024
Q2 		$248K Sell
12,701
-138,573
-92% -$3.54M ﹤0.01% 2424
2024
Q1 		$4.96M Buy
151,274
+44,119
+41% +$1.41M ﹤0.01% 1103
2023
Q4 		$3.54M Buy
107,155
+11,372
+12% +$322K ﹤0.01% 1276
2023
Q3 		$2.61M Buy
95,783
+7,626
+9% +$212K ﹤0.01% 1337
2023
Q2 		$2.67M Buy
+88,157
New +$2.85M ﹤0.01% 1315
2023
Q1 		– Sell
-14,494
Closed -$405K – 2783
2022
Q4 		$405K Sell
14,494
-5,290
-27% -$152K ﹤0.01% 2376
2022
Q3 		$724K Buy
19,784
+8,616
+77% +$304K ﹤0.01% 1990
2022
Q2 		$343K Sell
11,168
-7,417
-40% -$216K ﹤0.01% 2555
2022
Q1 		$600K Buy
18,585
+231
+1% +$6.05K ﹤0.01% 2282
2021
Q4 		$504K Buy
+18,354
New +$527K ﹤0.01% 2460
2020
Q3 		– Sell
-15,634
Closed -$111K – 2762
2020
Q2 		$111K Buy
+15,634
New +$105K ﹤0.01% 2504
2020
Q1 		– Sell
-31,155
Closed -$286K – 2788
2019
Q4 		$286K Sell
31,155
-44,248
-59% -$359K ﹤0.01% 2584
2019
Q3 		$542K Buy
+75,403
New +$541K ﹤0.01% 2292

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's EVH Position: Q1 2026 in Review

HSBC Holdings held its Evolent Health (EVH) position steady in Q1 2026 at 161,125 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

HSBC Holdings first reported a position in EVH in Q3 2019 and has held it in 19 quarters since. The position peaked at $4.96M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • HSBC Holdings held 161,125 shares of Evolent Health worth $362K as of Q1 2026.
  • HSBC Holdings left its Evolent Health share count unchanged in Q1 2026.
  • Evolent Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2370 holding.
  • HSBC Holdings first reported a position in Evolent Health in Q3 2019 and has held it in 19 quarters since.
  • HSBC Holdings's Evolent Health position peaked at $4.96M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.